Recent development in the discovery of PARP inhibitors as anticancer agents: a patent update (2016-2020)
{{output}}
Introduction: Discovery of small molecules that impede the activity of single-strand DNA repair enzyme, PARP1, has led to four marketed drugs for the treatment of advanced-stage cancers. Hence, there is a renewed enthusiasm in th... ...
